Published March, 2013
By Ann L. Jackman
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

---

Published January, 2013
By Jorge J. Castillo and Peter J. Quesenberry
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

This book will be the first that focuses on solely on model organisms for lymphoma. It's editors are internationally recognized in the field.

---

Published January, 2013
By Manuel Hidalgo, Neil J. Clendeninn, S. Gail Eckhardt and Elizabeth Garrett-Mayer
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

A practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.

---

Published January, 2013
By Vinata B. Lokeshwar, Axel S. Merseburger and Stefan H. Hautmann
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

Clinical management of bladder cancer is challenging because of the heterogeneity among bladder tumors with respect to invasion and metastasis, frequent occurrence of new tumors in the bladder among patients treated with bladder preservation treatments and poor prognosis of patients with tumors that invade the bladder muscle and beyond.

---

Published December, 2012
By Beverly A. Teicher and Gail Lewis Phillips
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

This volume gathers the leading research on antibody-drug conjugates and immunotoxins. Following a rigorous overview, the volume delves into focused sections on all aspects of ADCs and ITs from clinical development through to targeted therapeutic applications and the latest technologies.

---

Published December, 2012
By Moulay A. Alaoui-Jamali, Lawrence C. Panasci, Raquel Aloyz, Lawrence Panasci and Moulay Alaoui-Jamali
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

A comprehensive review of the recent developments in DNA repair research that have potential for translational applications.

---

Published November, 2012
By Saïd M. Sebti and Andrew D. Hamilton
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

---

Published November, 2012
By Frank E. Koehn
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

With reliable commentary and analysis in a sector often associated with outlandish claims, this volume provides a valuable overview of how natural products could generate new cancer therapeutics as well as mitigating the deleterious effects of chemotherapy.

---

Published November, 2012
By Rebecca G. Bagley
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

The fact that tumors are composed of both tumor cells and host cells has long been known. These tumor-associated cells include vascular endothelial cells and pe- cytes, as well as inflammatory cells such as neutrophils, monocytes, macrophages, mast cells and eosinophils, and lymphocytes.

---

Published October, 2012
By Vitaly A. Polunovsky and Peter J. Houghton
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

The target of rapamycin (TOR) was rst identi ed in Saccharomyces cerevisiae and subsequently in mammals (mTOR) as a conserved atypical serine/threonine kinase. Rapamycin was isolated as a product of the soil bacteria Streptomyces hygroscopicus, identi ed in a soil sample taken from the island of Rapa Nui (Easter Island).

---